In addition, melanoma cells pre-treated with ROCK inhibitors have shown suppressed tumor growth through the increase in the Fas ligand (FasL) and the corresponding infiltration of CD8+ T lymphocytes [144]. This evidence concerns the gene FASLG and neoplasm.